NIT
ASND icon

NumerixS Investment Technologies’s Ascendis Pharma A/S ASND Stock Holding History

NumerixS Investment Technologies’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-820
Closed -$94K – 1057
2019
Q1 		$94K Buy
+820
New +$71.8K 0.01% 872
2018
Q4 		– Sell
-200
Closed -$13K – 1075
2018
Q3 		$13K Buy
+200
New +$13.8K ﹤0.01% 1114

Other funds holding ASND

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

NumerixS Investment Technologies's ASND Position: Q2 2019 in Review

NumerixS Investment Technologies sold out of Ascendis Pharma A/S (ASND) in Q2 2019, closing a stake of 820 shares — an estimated $94K sold.

NumerixS Investment Technologies first reported a position in ASND in Q3 2018 and held it in 2 quarters. The position peaked at $94K in Q1 2019. 132 funds tracked by Wall St. Rank hold ASND as of Q2 2019.

  • NumerixS Investment Technologies reported no remaining Ascendis Pharma A/S position as of Q2 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 820 Ascendis Pharma A/S shares in Q2 2019, an estimated $94K.
  • NumerixS Investment Technologies first reported a position in Ascendis Pharma A/S in Q3 2018 and held it in 2 quarters.
  • NumerixS Investment Technologies's Ascendis Pharma A/S position peaked at $94K in Q1 2019.
  • 132 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2019.

Based on NumerixS Investment Technologies's 13F filing for Q2 2019, filed 13 Aug 2019.